These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37456249)

  • 21. Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion.
    Shin YM; Yun J; Lee OJ; Han HS; Lim SN; An JY; Lee KH; Lee KM; Choe KH
    Cancer Res Treat; 2014 Apr; 46(2):178-85. PubMed ID: 24851110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and
    Jreige M; Dunet V; Letovanec I; Prior JO; Meuli RA; Beigelman-Aubry C; Schaefer N
    J Nucl Med; 2020 Jan; 61(1):26-32. PubMed ID: 31227574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity Analysis of (18)F-FDG Uptake in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting.
    Budiawan H; Cheon GJ; Im HJ; Lee SJ; Paeng JC; Kang KW; Chung JK; Lee DS
    Nucl Med Mol Imaging; 2013 Dec; 47(4):232-41. PubMed ID: 24900118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
    Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
    Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
    Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Bertagna F; Prior JO; Ceriani L; Giovanella L
    Acad Radiol; 2014 Jan; 21(1):11-20. PubMed ID: 24331260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved detection of metastatic lymph nodes in oesophageal squamous cell carcinoma by combined interpretation of fluorine-18-fluorodeoxyglucose positron-emission tomography/computed tomography.
    Lee JY; Kim YH; Park YJ; Park SB; Chung HW; Zo JI; Shim YM; Lee KS; Choi JY
    Cancer Imaging; 2019 Jun; 19(1):40. PubMed ID: 31227017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDG PET of pleural effusions in patients with non-small cell lung cancer.
    Erasmus JJ; McAdams HP; Rossi SE; Goodman PC; Coleman RE; Patz EF
    AJR Am J Roentgenol; 2000 Jul; 175(1):245-9. PubMed ID: 10882281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
    Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
    Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters.
    Lee H; Chung YS; Lee JH; Lee KY; Hwang KH
    World J Clin Cases; 2022 Jan; 10(1):155-165. PubMed ID: 35071515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of preoperative (18)F-FDG PET-CT in lymphatic metastasis diagnosis of cutaneous malignant melanoma on extremities and trunk].
    Zhang XX; Fang Y; Xu LB; Xu SF; Zhao ZG; Sun C; Ma PQ; Liu T; Yu SJ; Zhang WJ
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):372-378. PubMed ID: 29860765
    [No Abstract]   [Full Text] [Related]  

  • 31. Dual-phase F-18 FDG PET-CT in staging and lymphoscintigraphy for detection of sentinel lymph nodes in oral cavity cancers.
    Sürücü E; Polack BD; Demir Y; Durmuşoğlu M; Ekmekçi S; Sarıoğlu S; Çelik AO; Ada E; İkiz AÖ
    Clin Imaging; 2015; 39(5):781-6. PubMed ID: 25721710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Derivation and validation of a 18F-FDG PET/CT scoring model to predict malignant pleural effusion.
    Lu P; Sun Y; Liang B; Yu L
    Nucl Med Commun; 2022 Feb; 43(2):177-185. PubMed ID: 34864810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion.
    Nakajima R; Abe K; Sakai S
    Medicine (Baltimore); 2015 Jul; 94(29):e1010. PubMed ID: 26200610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
    Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
    Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
    Zhai X; Guo Y; Qian X
    Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Value of 18F-FDG PET/CT in the Diagnosis of Tuberculous Pleurisy and in the Differential Diagnosis between Tuberculous Pleurisy and Pleural Metastasis from Lung Adenocarcinoma.
    Du X; Zhu F; Yu C
    Contrast Media Mol Imaging; 2022; 2022():4082291. PubMed ID: 35965614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving diagnostic performance of
    Yang DD; Mirvis E; Goldring J; Patel ARC; Wagner T
    Clin Radiol; 2019 Oct; 74(10):818.e17-818.e23. PubMed ID: 31420186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.
    Wang J; Fu J; Shen Q; Zhang F; Wang Y; Wu LL
    J Clin Lab Anal; 2019 Sep; 33(7):e22943. PubMed ID: 31268191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An initial study on the comparison of diagnostic performance of
    Wang ML; Zhang H; Yu HJ; Tan H; Hu LZ; Kong HJ; Mao WJ; Xiao J; Shi HC
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(1):16-23. PubMed ID: 36243657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleural carbohydrate antigen 50 and malignant pleural effusion: a prospective, double-blind diagnostic accuracy test.
    Cha SN; Niu Y; Wen JX; Yan C; Yang Q; Zhu HZ; Lin X; Cao XS; Gao WH; Wang YF; Zhou F; Yan L; Zheng WQ; Hu ZD
    Transl Lung Cancer Res; 2024 May; 13(5):1061-1068. PubMed ID: 38854948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.